KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Tenet Healthcare (THC) Equity Income (2016 - 2025)

Tenet Healthcare's Equity Income history spans 12 years, with the latest figure at $56.0 million for Q1 2025.

  • For Q1 2025, Equity Income fell 5.08% year-over-year to $56.0 million; the TTM value through Mar 2025 reached $257.0 million, up 8.44%, while the annual FY2025 figure was $264.0 million, 1.54% up from the prior year.
  • Equity Income for Q1 2025 was $56.0 million at Tenet Healthcare, down from $78.0 million in the prior quarter.
  • Across five years, Equity Income topped out at $78.0 million in Q4 2024 and bottomed at $42.0 million in Q1 2021.
  • The 5-year median for Equity Income is $54.0 million (2021), against an average of $57.5 million.
  • The largest annual shift saw Equity Income surged 755.56% in 2021 before it dropped 15.58% in 2022.
  • A 5-year view of Equity Income shows it stood at $77.0 million in 2021, then decreased by 15.58% to $65.0 million in 2022, then grew by 12.31% to $73.0 million in 2023, then increased by 6.85% to $78.0 million in 2024, then dropped by 28.21% to $56.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Equity Income are $56.0 million (Q1 2025), $78.0 million (Q4 2024), and $62.0 million (Q3 2024).